These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 17509803)

  • 1. A comparison of the activity of tigecycline against multiresistant clinical isolates of Staphylococcus aureus and Streptococcus agalactiae.
    Sorlozano A; Gutierrez J; Roman E; de Dios Luna J; Roman J; Liebana J; Piedrola G
    Diagn Microbiol Infect Dis; 2007 Aug; 58(4):487-9. PubMed ID: 17509803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the in vitro activity of tigecycline against multiresistant Gram-positive cocci containing tetracycline resistance determinants.
    Borbone S; Lupo A; Mezzatesta ML; Campanile F; Santagati M; Stefani S
    Int J Antimicrob Agents; 2008 Mar; 31(3):209-15. PubMed ID: 17646087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of daptomycin against multiresistant clinical isolates of Staphylococcus aureus and Streptococcus agalactiae.
    Sorlozano A; Gutiérrez J; Roman J; Liebana J; Piedrola G
    Microb Drug Resist; 2009 Jun; 15(2):125-7. PubMed ID: 19432525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity of tigecycline against recent isolates of respiratory pathogens from Asian countries.
    Ko KS; Song JH; Lee MY; Park S; Kwon KT; Heo ST; Ryu SY; Oh WS; Peck KR; Lee NY
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):337-41. PubMed ID: 16631337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers.
    Mendes RE; Sader HS; Deshpande L; Jones RN
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):433-6. PubMed ID: 18068326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in China.
    Wang H; Liu Y; Sun H; Xu Y; Xie X; Chen M
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):226-9. PubMed ID: 18653301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of tigecycline in combination with gentamicin against biofilm-forming Staphylococcus aureus.
    McConeghy KW; LaPlante KL
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):1-6. PubMed ID: 20727462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of staphylococcal bacteriocins against Staphylococcus aureus and Streptococcus agalactiae involved in bovine mastitis.
    Varella Coelho ML; Santos Nascimento JD; Fagundes PC; Madureira DJ; Oliveira SS; Vasconcelos de Paiva Brito MA; Freire Bastos Mdo C
    Res Microbiol; 2007 Sep; 158(7):625-30. PubMed ID: 17719749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    Rose WE; Poppens PT
    J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can interchangeability of lincosamides be assumed in clinical practice? Comparative MICs of clindamycin and lincomycin for Streptococcus pyogenes, Streptococcus agalactiae and Staphylococcus aureus.
    Porter MC; Henderson BA; Healy PE; Coombs GW; Ingram PR; McLellan D; Clark B
    J Antimicrob Chemother; 2014 Mar; 69(3):856-7. PubMed ID: 24164721
    [No Abstract]   [Full Text] [Related]  

  • 11. Baseline in vitro activity of tigecycline among key bacterial pathogens exhibiting multidrug resistance.
    Draghi DC; Tench S; Dowzicky MJ; Sahm DF
    Chemotherapy; 2008; 54(2):91-100. PubMed ID: 18303257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of tigecycline against clinical isolates of Staphylococcus aureus and extended-spectrum beta-lactamase-producing Escherichia coli in Granada, Spain.
    Sorlózano A; Gutiérrez J; Salmerón A; Luna JD; Martínez-Checa F; Román J; Piédrola G
    Int J Antimicrob Agents; 2006 Dec; 28(6):532-6. PubMed ID: 17045785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study.
    Betriu C; Rodríguez-Avial I; Gómez M; Culebras E; López F; Alvarez J; Picazo JJ;
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):437-44. PubMed ID: 16949245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
    Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of tigecycline (GAR-936) tested against 3498 recent isolates of Staphylococcus aureus recovered from nosocomial and community-acquired infections.
    Fritsche TR; Jones RN
    Int J Antimicrob Agents; 2004 Dec; 24(6):567-71. PubMed ID: 15555879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline.
    Fluit AC; Florijn A; Verhoef J; Milatovic D
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1636-8. PubMed ID: 15793159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of JNJ-Q2 activity tested against Staphylococcus aureus and beta-hemolytic streptococci as a component of the 2010 SENTRY Antimicrobial Surveillance Program.
    Farrell DJ; Liverman LC; Biedenbach DJ; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2011 Dec; 71(4):415-20. PubMed ID: 21982563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of daptomycin, tigecycline, linezolid and eight other antibiotics, alone and in combination, against 41 Staphylococcus spp. clinical isolates from bone and joint infections.
    Kuli B; de Barbeyrac B; Dauchy FA; Dutronc H; Bébéar C; Mégraud F; Dupon M
    Int J Antimicrob Agents; 2009 May; 33(5):491-3. PubMed ID: 19153031
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of tigecycline and occurrence of tetracycline resistance determinants in isolates from patients enrolled in phase 3 clinical trials for community-acquired pneumonia.
    Bradford PA; Petersen PJ; Tuckman M; Jones CH
    Clin Microbiol Infect; 2008 Sep; 14(9):882-6. PubMed ID: 18844692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of iclaprim against clinical isolates of Streptococcus pyogenes and Streptococcus agalactiae.
    Morrissey I; Maher K; Hawser S
    J Antimicrob Chemother; 2009 Feb; 63(2):413-4. PubMed ID: 19059943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.